| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |